Skip to main content
SpringerLink
Log in

Effects of parathyroidectomy on blood bone markers and heart rate variability in patients with stage 5 chronic kidney disease

  • Nephrology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose

Decreased heart rate variability (HRV) is closely related to abnormal cardiac autonomic nervous function, especially sympathetic hyperactivity, which intensifies the risk of cardiovascular events and sudden death. HRV parameters are lower in chronic kidney disease (CKD) and parathyroidectomy (PTX) can improve these abnormalities in severe secondary hyperparathyroidism (SHPT) patients. However, few studies have evaluated correlations between circulating bone markers and HRV in CKD patients.

Methods

We conducted a cross-sectional study including 134 stage 5 CKD patients with 100 controls and a prospective study of 29 PTX patients with follow-up. Circulating bone biomarkers included: (1) intact parathyroid hormone (iPTH) as bone remodeling regulator; (2) bone-specific alkaline phosphatase (BAP), representing bone formation; (3) tartrate-resistant acid phosphatase 5b (TRACP-5b), indicating bone resorption; and (4) bone-derived hormone, fibroblast growth factor 23 (FGF23).

Results

Stage 5 CKD patients had higher circulating iPTH, BAP, TRACP-5b, and FGF23 than controls and these bone markers were significantly elevated in SHPT patients. Baseline iPTH, BAP, and lnFGF23 were independently associated with HRV in CKD patients. After PTX with a follow-up (median interval: 6.7 months), high blood iPTH, BAP, TRACP-5b, FGF23, and attenuated HRV were ameliorated. Furthermore, improved HRV indices were associated with reduced iPTH, BAP, TRACP-5b, and FGF23.

Conclusions

Circulating bone markers are correlated with HRV in CKD 5 patients and PTX can improve decreased HRV, which are associated with corrected bone markers in severe SHPT patients. Thus, we propose that PTH increases sympathetic tone and both high circulating PTH levels and sympathetic hyperactivity increase bone turnover, and that the products of bone turnover influence HRV.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Saran R, Robinson B, Abbott KC et al (2017) US renal data system 2016 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis 69(3S1):A7–A8. https://doi.org/10.1053/j.ajkd.2016.12.004

    Article  PubMed  Google Scholar 

  2. Park J (2012) Cardiovascular risk in chronic kidney disease: role of the sympathetic nervous system. Cardiol Res Pract 2012:319432. https://doi.org/10.1155/2012/319432

    Article  PubMed  PubMed Central  Google Scholar 

  3. Chandra P, Sands RL, Gillespie BW et al (2012) Predictors of heart rate variability and its prognostic significance in chronic kidney disease. Nephrol Dial Transpl 27(2):700–709. https://doi.org/10.1093/ndt/gfr340

    Article  CAS  Google Scholar 

  4. Huang JC, Kuo IC, Tsai YC et al (2017) Heart rate variability predicts major adverse cardiovascular events and hospitalization in maintenance hemodialysis patients. Kidney Blood Press Res 42(1):76–88. https://doi.org/10.1159/000469716

    Article  CAS  PubMed  Google Scholar 

  5. Zhang J, Yu X, Sun B et al (2013) Parathyroidectomy and heart rate variability in patients with stage 5 CKD. Clin J Am Soc Nephrol 8(8):1378–1387. https://doi.org/10.2215/CJN.10381012

    Article  PubMed  PubMed Central  Google Scholar 

  6. Zhang LN, Yang G, Cheng C et al (2015) Plasma FGF23 levels and heart rate variability in patients with stage 5 CKD. Osteoporos Int 26 (1):395–405. https://doi.org/10.1007/s00198-014-2862-7

    Article  CAS  PubMed  Google Scholar 

  7. Sardiwal S, Gardham C, Coleman AE et al (2012) Bone-specific alkaline phosphatase concentrations are less variable than those of parathyroid hormone in stable hemodialysis patients. Kidney Int 82(1):100–105. https://doi.org/10.1038/ki.2012.77

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Henriksen K, Tanko LB, Qvist P et al (2007) Assessment of osteoclast number and function: application in the development of new and improved treatment modalities for bone diseases. Osteoporos Int 18 (5):681–685. https://doi.org/10.1007/s00198-006-0286-8

    Article  CAS  PubMed  Google Scholar 

  9. Yamada S, Inaba M, Kurajoh M et al (2008) Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction. Clin Endocrinol 69(2):189–196. https://doi.org/10.1111/j.1365-2265.2008.03187.x

    Article  CAS  Google Scholar 

  10. Zhang L, Long J, Jiang W et al (2016) Trends in chronic kidney disease in China. New Engl J Med 375(9):905–906. https://doi.org/10.1056/NEJMc1602469

    Article  PubMed  Google Scholar 

  11. Paula FJ, Lanna CM, Shuhama T et al (2001) Effect of metabolic control on parathyroid hormone secretion in diabetic patients. Braz J Med Biol Res 34(9):1139–1145. https://doi.org/10.1590/S0100-879X2001000900006

    Article  CAS  PubMed  Google Scholar 

  12. Al Salmi I, AlRukhaimi M, AlSahow A et al (2016) Mineral bone disorder and its management among hemodialysis patients in the Gulf Cooperation Council: initial findings from the dialysis outcomes and practice patterns study (2012–2015). Saudi J Kidney Dis Transpl 27(Supplement):62–80. https://doi.org/10.4103/1319-2442.194902

    Article  PubMed  Google Scholar 

  13. Evenepoel P, Bover J, Urena Torres P (2016) Parathyroid hormone metabolism and signaling in health and chronic kidney disease. Kidney Int 90(6):1184–1190. https://doi.org/10.1016/j.kint.2016.06.041

    Article  CAS  PubMed  Google Scholar 

  14. Davina JJ, Priyadarssini M, Rajappa M et al (2017) Assessment of bone turnover markers to predict mineral and bone disorder in men with pre-dialysis non-diabetic chronic kidney disease. Clin Chim Acta 469:195–200. https://doi.org/10.1016/j.cca.2017.04.010

    Article  CAS  PubMed  Google Scholar 

  15. Kurajoh M, Inaba M, Okuno S et al (2011) Reduction of whole PTH/intact PTH ratio as a predictor of bone metabolism in cinacalcet treatment of hemodialysis patients with secondary hyperparathyroidism. Osteoporos Int 22 (3):923–930. https://doi.org/10.1007/s00198-010-1262-x

    Article  CAS  PubMed  Google Scholar 

  16. Tolouian R, Hernandez GT, Chiang WY et al (2010) A new approach for evaluating bone turnover in chronic kidney disease. Eur J Intern Med 21(3):230–232. https://doi.org/10.1016/j.ejim.2010.01.013

    Article  PubMed  Google Scholar 

  17. Zhang J, Wang N (2014) Prognostic significance and therapeutic option of heart rate variability in chronic kidney disease. Int Urol Nephrol 46(1):19–25. https://doi.org/10.1007/s11255-013-0421-3

    Article  CAS  PubMed  Google Scholar 

  18. Ferrario M, Raimann JG, Larive B et al (2015) Non-linear heart rate variability indices in the frequent hemodialysis network trials of chronic hemodialysis patients. Blood Purif 40(1):99–108. https://doi.org/10.1159/000381665

    Article  PubMed  PubMed Central  Google Scholar 

  19. Oikawa K, Ishihara R, Maeda T et al (2009) Prognostic value of heart rate variability in patients with renal failure on hemodialysis. Int J Cardiol 131(3):370–377. https://doi.org/10.1016/j.ijcard.2007.10.033

    Article  PubMed  Google Scholar 

  20. Buonacera A, Boukhris M, Tomasello SD et al (2016) Impact of left ventricular remodeling and renal function on 24 h-ECG recordings and cardiovascular outcome in elderly hypertensive patients. Eur J Intern Med 29:71–77. https://doi.org/10.1016/j.ejim.2016.01.001

    Article  PubMed  Google Scholar 

  21. Roumelioti ME, Ranpuria R, Hall M et al (2010) Abnormal nocturnal heart rate variability response among chronic kidney disease and dialysis patients during wakefulness and sleep. Nephrol Dial Transpl 25(11):3733–3741. https://doi.org/10.1093/ndt/gfq234

    Article  Google Scholar 

  22. Ussawawongaraya W, Spilles N, Nilwarangkoon S et al (2013) The correlation of parathyroid hormone and heart rate variability in CAPD patients. J Med Assoc Thai 96(5):595–602

    PubMed  Google Scholar 

  23. Tentori F, Wang M, Bieber BA et al (2015) Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study. Clin J Am Soc Nephrol 10(1):98–109. https://doi.org/10.2215/CJN.12941213

    Article  CAS  PubMed  Google Scholar 

  24. Bliziotes M, McLoughlin S, Gunness M et al (2000) Bone histomorphometric and biomechanical abnormalities in mice homozygous for deletion of the dopamine transporter gene. Bone 26(1):15–19

    Article  CAS  Google Scholar 

  25. Seger RL, Cross RA, Rosen CJ et al (2011) Investigating the mechanism for maintaining eucalcemia despite immobility and anuria in the hibernating American black bear (Ursus americanus). Bone 49(6):1205–1212. https://doi.org/10.1016/j.bone.2011.08.017

    Article  CAS  PubMed  Google Scholar 

  26. Fahrleitner-Pammer A, Herberth J, Browning SR et al (2008) Bone markers predict cardiovascular events in chronic kidney disease. J Bone Min Res 23(11):1850–1858. https://doi.org/10.1359/jbmr.080610

    Article  CAS  Google Scholar 

  27. Faul C, Amaral AP, Oskouei B et al (2011) FGF23 induces left ventricular hypertrophy. J Clin Invest 121(11):4393–4408. https://doi.org/10.1172/jci46122

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Longenecker JC, Zubaid M, Johny KV et al (2009) Association of low heart rate variability with atherosclerotic cardiovascular disease in hemodialysis patients. Med Principles Pract 18(2):85–92. https://doi.org/10.1159/000189804

    Article  CAS  Google Scholar 

  29. Nishimura M, Hashimoto T, Kobayashi H et al (2004) Association between cardiovascular autonomic neuropathy and left ventricular hypertrophy in diabetic haemodialysis patients. Nephrol Dial Transpl 19(10):2532–2538. https://doi.org/10.1093/ndt/gfh361

    Article  Google Scholar 

  30. Shimada T, Urakawa I, Isakova T et al (2010) Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active. J Clin Endocrinol Metab 95(2):578–585. https://doi.org/10.1210/jc.2009-1603

    Article  CAS  PubMed  Google Scholar 

  31. Wesseling-Perry K (2011) FGF23: is it ready for prime time? Clin Chem 57(11):1476–1477. https://doi.org/10.1373/clinchem.2011.172890

    Article  CAS  PubMed  Google Scholar 

  32. Connelly K, Collister D, Tangri N (2018) Fracture risk and treatment in chronic kidney disease. Curr Opin Nephrol Hypertens 27(3):221–225

    Google Scholar 

  33. Benson T, Menezes T, Campbell J et al (2016) Mechanisms of vasodilation to PTH 1-84, PTH 1-34, and PTHrP 1-34 in rat bone resistance arteries. Osteoporos Int 27(5):1817–1826

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Qing Ma and Yanyan Pan for the care and management of the patients; Yun Xia, Zhihui Song, Jing Tu and Saijun Yang for assistance with the analysis of heart rate variability. This work was funded by the National Natural Science Foundation of China (81270408, 81570666), International Society of Nephrology (ISN) Clinical Research Program (18-01-0247), Construction Program of Jiangsu Provincial Clinical Research Center Support System (BL2014084), Chinese Society of Nephrology (13030300415), Jiangsu Province Key Medical Personnel Project (RC201162, ZDRCA2016002), and Six Major Talents Summit of Jiangsu Province ([2010-WS-026]).

Author information

Authors and Affiliations

  1. Department of Nephrology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, Jiangsu, People’s Republic of China

    Huimin Chen, Ying Cui, Changying Xing, Yogendranath Purrunsing, Ming Zeng, Guang Yang, Xiangbao Yu, Lina Zhang, Yao Jiang, Haoyang Ma, Caixia Yin & Ningning Wang

  2. Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, People’s Republic of China

    Xiaoming Zha

  3. Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, People’s Republic of China

    Chong Shen

  4. Department of Nephrology, Jiangsu Province Geriatric Hospital, Nanjing, People’s Republic of China

    Zhixiang Shen

  5. Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, People’s Republic of China

    Yunfei Li

Authors
  1. Huimin Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ying Cui
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Changying Xing
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yogendranath Purrunsing
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xiaoming Zha
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Chong Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ming Zeng
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Guang Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Xiangbao Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Lina Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Yao Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Zhixiang Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Haoyang Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Caixia Yin
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Yunfei Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Ningning Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Yunfei Li or Ningning Wang.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, H., Cui, Y., Xing, C. et al. Effects of parathyroidectomy on blood bone markers and heart rate variability in patients with stage 5 chronic kidney disease. Int Urol Nephrol 50, 2279–2288 (2018). https://doi.org/10.1007/s11255-018-1995-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-018-1995-6

Keywords

Search

Navigation